These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38470)

  • 1. The role of depot neuroleptics in the treatment of schizophrenic patients.
    Levine J; Schooler NR; Cassano GB
    Psychol Med; 1979 May; 9(2):383-6. PubMed ID: 38470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Depot neuroleptics in social psychiatric practice].
    Pruss U; Rose HK; Zechner A
    Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schizophrenia: prophylaxis prevents recurrence. Low dose depot neuroleptics--an exit from the "revolving door" psychiatry].
    Fortschr Med Suppl; 1993; 147():1-15. PubMed ID: 9260317
    [No Abstract]   [Full Text] [Related]  

  • 5. [The psychoprophylactic importance of treatment with depot neuroleptics in schizophrenia].
    Chiriţă V; Stanciu J; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):497-500. PubMed ID: 2576888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
    Knudsen P
    Acta Psychiatr Scand Suppl; 1985; 322():51-75. PubMed ID: 2866666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot neuroleptics: side effects and safety.
    Marder SR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot neuroleptic therapy: an underutilized treatment option.
    Glazer WM; Kane JM
    J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term therapy with depot neuroleptics. Prevention of recurrence in chronic schizophrenic patients].
    Bergener M; Husser J; Kranzhoff EU; Charap A
    Fortschr Med; 1986 Oct; 104(40):756-60. PubMed ID: 2877927
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabis and neuroleptic agents in schizophrenia.
    Knudsen P; Vilmar T
    Acta Psychiatr Scand; 1984 Feb; 69(2):162-74. PubMed ID: 6142585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics.
    Herrán A; García-Unzueta MT; Fernández-González MD; Vázquez-Barquero JL; Alvarez C; Amado JA
    Psychiatry Res; 2000 Apr; 94(1):51-8. PubMed ID: 10788677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eleven years of experience with depot neuroleptics.
    Gross H; Kaltenbäck E; Pfolz H
    Acta Psychiatr Belg; 1981; 81(2):128-32. PubMed ID: 6117183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects and side effects of depot neuroleptics as perceived by patients].
    Trenckmann U
    Psychiatr Prax; 1990 Sep; 17(5):184-7. PubMed ID: 1980015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve years' experience with the total use of depot neuroleptics in a defined population.
    Freeman H
    Adv Biochem Psychopharmacol; 1980; 24():559-64. PubMed ID: 6105801
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic maintenance treatment of schizophrenia patients: is there a consensus?
    Meise U; Kurz M; Fleischhacker WW
    Schizophr Bull; 1994; 20(1):215-25. PubMed ID: 7910977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot neuroleptics in relapse prevention: advantages and disadvantages.
    Gerlach J
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 5():17-20. PubMed ID: 7622829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of long-acting neuroleptics in the treatment of schizophrenia].
    Levine J; Schooler NR; Cassano G
    Encephale; 1979; 5(3):285-90. PubMed ID: 39740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How schizophrenic patients change during 3 years' treatment with depot neuroleptics.
    Dencker SJ; Frankenberg K; Lepp M; Lindberg D; Malm U
    Acta Psychiatr Scand; 1978 Feb; 57(2):115-23. PubMed ID: 24982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.